Intan Sofia Omar. (2022). Abnormal progesterone receptor signaling in endometrial cancer-associated fibroblasts contributes to medroxyprogesterone acetate resistance in endometrial cancer: Intan Sofia Omar.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Intan Sofia Omar. Abnormal Progesterone Receptor Signaling in Endometrial Cancer-associated Fibroblasts Contributes to Medroxyprogesterone Acetate Resistance in Endometrial Cancer: Intan Sofia Omar. 2022.
توثيق جمعية اللغة المعاصرة MLA (الطبعة الثامنة)Intan Sofia Omar. Abnormal Progesterone Receptor Signaling in Endometrial Cancer-associated Fibroblasts Contributes to Medroxyprogesterone Acetate Resistance in Endometrial Cancer: Intan Sofia Omar. 2022.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.